Controlling contagious bacterial conjunctivitis

Journal of Pediatric Ophthalmology and Strabismus

Volumn 43, Issue 1, 2006, Pages 19-26

  Lichtenstein, Steven J ^a   Dorfman, Mark ^b   Kennedy, Robert ^c   Stroman, David ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JOE DIMAGGIO CHILDREN S HOSPITAL   (United States)

^c North Texas Ophthalmic Plastic Surgery   (United States)

^d ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; MOXIFLOXACIN; POLYTRIM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CASE REPORT; CELL CULTURE; CELL SEPARATION; CELL VIABILITY; CHILD; CONJUNCTIVITIS; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; NEWBORN; NONHUMAN; PRESCRIPTION; STREPTOCOCCUS PNEUMONIAE; TEAR FILM;

EID: 31944452500     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/01913913-20060101-02     Document Type: Article

References (23)

1. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 2003;348:1112-1121.
2. Centers for Disease Control and Prevention. Outbreak of bacterial conjunctivitis at a college: New Hampshire, January-March, 2002. MMWR 2002;51:205-207.
3. Minnesota Department of Health. Outbreak of conjunctivitis due to Streptococcus pneumoniae. Disease Control Newsletter 2004;32:6-8.
4. Centers for Disease Control and Prevention. Pneumococcal conjunctivitis at an elementary school: Maine, September 20-December 6, 2002. MMWR? 2003;52:64-66.
5. Syed NA, Chandler JW. Bacterial conjunctivitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye, ed. 2. Boston: Little, Brown; 1996:423-431.
6. Leibowitz HM. Primary care: the red eye. N Engl J Med 2000;343: 345-351.
7. Chin J, ed. Control of Communicable Diseases Manual, ed. 17. Washington, DC: American Public Health Association; 2000.
8. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis 2001;33:S187-S192.
9. Centers for Disease Control and Prevention. Resistance of Streptococcus pneumoniae to fluoroquinolones: United States, 1995-1999. MMWR 2001;50:800-804.
10. Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005;11:802-807.
11. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 2004;49:S79-S83.
12. Mah FS. New antibiotics for bacterial infections. Ophthalmol Clin North Am 2003;16:11-27.
13. Schedletzky H, Wiedemann B, Heisig P. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother 1999;43(suppl B):31-37.
14. Balfour JA, Lamb HM. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs 2000;59:115-139.
15. Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2000;31(suppl 2):S24-S28.
16. Kishii R, Takei M, Fukuda H, Hayashi K, Hosaka M. Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae. Antimicrob Agents Chemother 2003;47:77-81.
17. Blondeau JM. Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004;49:S73-S78.
18. Block SL, Hedrick J, Tyler R, et al. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother 2000;44:1650-1654.
19. Penland RL, Wilhelmus KR. Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections. Cornea 1998;17:135-140.
20. Stroman DW, Dajcs JJ, Cupp GA, Schlech BA. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Surv Ophthalmol 2005;50:S16-S31.
21. Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol 2005;123:1282-1283.
22. Trottier S, Stenberg K, Von Rosen IA, Svanborg C. Haemophilus influenzae causing conjunctivitis in day-care children. Pediatr Infect Dis J 1991;10:578-584.
23. Schwartz B, Harrison LH, Motter JS, Motter RN, Hightower AW, Broome CV. Investigation of an outbreak of Moraxella conjunctivitis at a Navajo boarding school. Am J Ophthalmol 1989;107:341-347.